Parainfluenza is an acute infectious disease caused by the parainfluenza virus, which belongs to the Paramyxoviridae family. This viral infection primarily affects the upper respiratory tract and is considered the main causative agent of acute respiratory infections in children and adults. The disease manifests itself with clinical symptoms resembling influenza, including fever, runny nose, cough, sore throat and general weakness. Parainfluenza is characterized by light periods when symptoms may weaken, however, in severe cases, it can lead to serious complications such as laryngeal stenosis or bronchitis.
History of the disease and interesting historical facts
Parainfluenza was first described in the early 20th century, but its virus was not isolated until the 1950s. One of the first reported cases of parainfluenza was in children, which helped establish a link between the virus and respiratory diseases in this age group. For decades, researchers have studied the epidemiology and pathogenesis of parainfluenza, as well as its impact on public health. There are many known epidemics of parainfluenza, especially in children's groups, where outbreaks of the disease occur due to close contact and high susceptibility of children to the virus. This disease continues to be a pressing public health problem that requires constant monitoring and prevention.
Epidemiology
The epidemiology of parainfluenza shows a high prevalence of this disease, especially among preschool and primary school children. According to the World Health Organization, during epidemics, the incidence rate can reach 20-30% among children attending educational institutions. The most frequent cases of the disease are recorded in the autumn-winter period, when there is a seasonal increase in respiratory infections. Adults are also susceptible to this infection, although most cases in the adult population are mild. Research in recent decades has shown that parainfluenza can cause serious complications in people with weakened immunity and in the elderly, which requires a more careful approach to monitoring this category of patients.
Genetic predisposition to this disease
Susceptibility to parainfluenza may be partly determined by genetic predisposition. Research suggests that certain mutations in genes involved in the immune response may contribute to an increased risk of the disease. In particular, polymorphisms in genes associated with the production of interferons and other cytokines may affect the body's ability to resist infections, including parainfluenza virus. Analysis of data has shown that some people with certain genetic markers are more likely to become infected and have a more severe course of the disease, while others may remain immune.
Risk factors for the development of this disease
Risk factors that contribute to the development of parainfluenza can be divided into several categories:
- Physical factors: the presence of chronic lung and cardiovascular diseases, which increases the risk of severe disease.
- Chemical factors: Exposure to pollutants such as tobacco smoke and chemicals can weaken the immune system.
- Social factors: living in densely populated areas, which increases the risk of transmission of the virus.
- Age: Children under 5 years of age, older adults, and people with weakened immune systems are at increased risk.
- Seasonality: a high probability of illness is observed in the autumn-winter period, when there is high activity of viruses.
Diagnosis of this disease
Diagnosis of parainfluenza is based on clinical analysis of symptoms and background examination. The main symptoms include:
- Fever and chills.
- Cough (often dry and persistent).
- Sore throat.
- Runny nose and nasal congestion.
- General weakness and headache.
The following laboratory tests may be used to confirm the diagnosis:
- PCR (polymerase chain reaction) to detect the virus.
- Enzyme immunoassay for antibodies to parainfluenza viruses.
Radiological examinations such as chest X-ray may be used to exclude pneumonia in severe cases. Differential diagnosis should include influenza, respiratory viral infections, and allergic conditions.
Treatment
Treatment of parainfluenza is mainly symptomatic and aimed at alleviating the patient's condition. The main principles of treatment include:
- General treatment: bed rest, fluid intake and consultation with a doctor are necessary.
- Pharmacological treatment: antipyretics (paracetamol, ibuprofen) are used to reduce the temperature, as well as drugs to relieve symptoms (for example, antihistamines).
- Surgery: In rare cases, such as laryngeal stenosis, surgery may be needed to open the airway.
- Other treatments include inhalations, physiotherapy and contraction therapy to relieve symptoms and speed up the healing process.
List of medications used to treat this disease
The following medications may be prescribed as part of the treatment for parainfluenza:
- Paracetamol (antipyretic)
- Ibuprofen (anti-inflammatory)
- Loratadine (antihistamine)
- Cough syrups with codeine (for severe cough)
- Decongestants (to reduce swelling of the nasal mucosa)
Disease monitoring
Monitoring the condition of a patient with parainfluenza requires constant monitoring of key vital signs. The following are mandatory steps:
- Regularly assess body temperature to detect fever.
- Monitor symptoms: cough, difficulty breathing and general well-being.
- Prognosis: Most patients recover completely, but there is a risk of complications in high-risk groups.
- Complications: May include pneumonia, bronchitis, and laryngeal stenosis.
Age-related features of the disease
Parainfluenza can manifest itself differently depending on the age group:
- In children: the disease is often accompanied by more pronounced symptoms and the risk of complications, since their airways are not yet fully formed.
- In older people: the disease may be more severe due to the presence of concomitant diseases, which increases the risk of complications.
- In adults: Symptoms may be less severe, but the risk of complications remains high for people with weakened immune systems.
Questions and Answers
- How does parainfluenza manifest itself? Parainfluenza causes symptoms such as fever, cough, sore throat and runny nose, often accompanied by general malaise.
- What is the prevention of parainfluenza? Prevention includes regular hand washing, avoiding contact with sick people, and vaccination against other respiratory viruses.
- How long does parainfluenza last? Parainfluenza usually lasts from 3 to 7 days, but can be combined with other infections, which prolongs the recovery period.
- Can parainfluenza lead to complications? Yes, parainfluenza can lead to complications such as laryngeal stenosis, pneumonia and bronchitis, especially in children and the elderly.
- How is parainfluenza treated? Treatment is symptomatic: use of antipyretic drugs, inhalations and other methods to alleviate the patient's condition.
